As this recent NY Times article on Psychiatric Fraud brings to light, there is a lot of money flowing from drug companies to the psychiatrists who review their drugs. As reported in this story, Dr. Charles B. Nemeroff of Emory University, who has been a “leading light” in psychiatry with over 850 articles published, and who held the position of editor in chief at Neuropsychopharmacology, a “prestigious” journal in which psych drugs are discussed and reviewed. Dr. Nemeroff has received over $170,000 in just one year from GlaxoSmithKline. So basically he has been hip-deep in the pockets of the very drug companies whose drugs he is “reviewing” and promoting in his journal.
And Dr. Nemeroff is not alone in this — MANY psychiatrists are receiving huge grants and speaking fees from psych drug companies. The drug companies of course want profits, and they don’t care who they have to pay to get their drugs accepted and then prescribed in staggering numbers.
This has to stop. Find out what you can do about it by visiting www.cchr.org.
Senator Charles Grassley (R) Iowa is systematically investigating which companies have paid how much to which doctors and is slowly uncovering this snake pit of lies, fraud and deception. Of course he’s moving at a snail’s pace, as he is doing it all officially and dragging it into the light of day. Thank you, Senator Grassley!
These psychs need to be incarcerated for fraud, and the drug companies that have been paying them off need to have their boards of directors jailed.